IP Verse

Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis - EP3351246

PATENT ANALYSIS

Patent Details

Grant Date
Sep 18, 2019
Company
NOVARTIS AG
Oppositions

ACCORD HEALTHCARE LTD

ARROW GENERIQUES

BIOGARAN

DR. REDDY'S LABORATORIES LTD./ BETAPHARM ARZNEIMITTEL GMBH

ETHYPHARM

GENERICS [UK] LIMITED

STADA ARZNEIMITTEL AG

TEVA PHARMACEUTICAL INDUSTRIES LTD.

ZENTIVA PHARMA GMBH

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you